Leniolisib: a novel treatment for activated phosphoinositide-3 kinase delta syndrome

被引：2
|
作者：
De, Surya K. [1 ,2 ]
机构：
[1] Conju Probe, San Diego, CA 92121 USA
[2] Bharath Univ, Dept Chem, Chennai, Tamil Nadu, India
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
关键词：
idelalisib; duvelisib; copanlisib; alpelisib; leniolisib; phosphatidylinositol; 3-kinase; PI3K/AKT SIGNALING PATHWAY; PI3K-DELTA; DISCOVERY;
D O I：
10.3389/fphar.2024.1337436
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
(Figure presented.) Copyright © 2024 De.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma
    Rascoe, PA
    Cao, XB
    Daniel, JC
    Miller, SD
    Smythe, WR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (02): : 393 - 400
  • [22] A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS)
    Hitchcock, Ian
    Skrobanski, Hanna
    Matter, Elina
    Munro, Ewen
    Whalen, John
    Nolthenius, Joanne Tutein
    Crocker-Buque, Alex
    Harrington, Amanda
    Vandenberghe, Delphine
    Acaster, Sarah
    Williams, Kate
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [23] The phosphoinositide-3 kinase signaling is involved in neuroinflammation in hypertensive rats
    Tan, Xing
    Jiao, Pei-Lei
    Wang, Yang-Kai
    Wu, Zhao-Tang
    Zeng, Xiao-Rong
    Li, Miao-Ling
    Wang, Wei-Zhong
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (04) : 350 - 359
  • [24] The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
    Oudit, GY
    Sun, H
    Kerfant, BG
    Crackower, MA
    Penninger, JM
    Backx, PH
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (02) : 449 - 471
  • [25] PLENIOLISIB REVERSES PULMONARY DYSFUNCTION AND IMMUNE DEFICIENCY IN ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME
    Menezes, Summer
    Limaye, Sandhya
    Hu, Hannah
    Wong, Melanie
    Morgan, Lucy
    Moore, John
    Tangye, Stuart
    Deenick, Elissa
    Kane, Alisa
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 41 - 42
  • [26] OVERALL SURVIVAL (OS) AMONG PATIENTS WITH ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS)
    Harrington, A.
    Mahendran, M.
    Ramasubramanian, R.
    Memmott, H.
    Germain, G.
    Busch, K.
    Laliberte, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S63 - S64
  • [27] Activated phosphoinositide 3-kinase delta syndrome type I in a patient with significant neurodevelopmental delay
    Mannelli, Jorge
    Garcia-Cuesta, Daniel
    Sanchez-Codez, Maria
    Peromingo-Matute, Estrella
    Mora-Lopez, Francisco
    De la Varga-Martinez, Raquel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1026 - 1026
  • [28] Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
    Aoyagi, Toshinori
    Matsui, Takashi
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (18) : 1818 - 1824
  • [29] Effect of phosphoinositide-3 kinase inhibition on Legionella pneumophila phagocytosis
    Khelef, N
    Shuman, HA
    Maxfield, FR
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2622 - 2622
  • [30] Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer
    James M. Cleary
    Geoffrey I. Shapiro
    Current Oncology Reports, 2010, 12 : 87 - 94
12345